Clinical Trials Browser

Phase 2/3 × Carcinoma × Radiation × Clear all

NCT05050162 2026-03-03

Comparing Cisplatin Every Three Weeks to Cisplatin Weekly When Combined With Radiation for Patients With Advanced Head and Neck Cancer

Phase 2/3 Suspended

Carcinoma, Oropharyngeal Neoplasms

NCT05144100 2021-12-03

SCOPE

Phase 2/3 Not yet recruiting

Carcinoma